CM Life Sciences II, Inc. (CMII)
|Net Income (ttm)||n/a|
|Trading Day||March 2|
|Day's Range||13.35 - 13.68|
|52-Week Range||11.75 - 14.26|
CM Life Sciences II Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Closing of $276 Million Initial Public Offering
NEW YORK--(BUSINESS WIRE)--CM Life Sciences II Inc. (the “Company”) announced today that it closed its initial public offering of 27,600,000 units at $10.00 per unit, including 3,600,000 units...
CM Life Sciences II Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $240 Million Initial Public Offering
CM Life Sciences II Inc. (the “Company”) announced today that it priced its initial public offering of 24,000,000 units at $10.00 per unit.
CM Life Sciences II, Inc. has filed to go public with an IPO on the NASDAQ.
CM Life Sciences II is a newly organized blank check company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. We intend to capitalize on our management team’s background and experience to identify promising opportunities in the life sciences sector. Our sponsor is an affiliate of Eli Casdin, founder and Chief Investment Officer of Casdin Capital, and of Keith Meister, founder and Chief Investment Officer of... [Read more...]
Blank Checks / SPAC
|IPO Date |
Feb 23, 2021
|Stock Exchange |
|Ticker Symbol |